Literature DB >> 28169198

Lung cancer survival only increases by a small amount despite recent treatment advances.

Sanjeet Bagcchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28169198     DOI： 10.1016/S2213-2600(17)30041-3

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  19 in total

1.  Novel genetic variants of SYK and ITGA1 related lymphangiogenesis signaling pathway predict non-small cell lung cancer survival.

Authors:  Lihua Liu; Hongliang Liu; Sheng Luo; Edward F Patz; Carolyn Glass; Li Su; Lijuan Lin; David C Christiani; Qingyi Wei
Journal:  Am J Cancer Res       Date:  2020-08-01       Impact factor: 6.166

2.  Effects of Selenium Nanoparticles Combined With Radiotherapy on Lung Cancer Cells.

Authors:  Jingxia Tian; Xiaoying Wei; Weihua Zhang; Aiguo Xu
Journal:  Front Bioeng Biotechnol       Date:  2020-11-16

3.  Extracellular Vesicle Mediated Tumor-Stromal Crosstalk Within an Engineered Lung Cancer Model.

Authors:  Kayla F Goliwas; Hannah M Ashraf; Anthony M Wood; Yong Wang; Kenneth P Hough; Sandeep Bodduluri; Mohammad Athar; Joel L Berry; Selvarangan Ponnazhagan; Victor J Thannickal; Jessy S Deshane
Journal:  Front Oncol       Date:  2021-04-23       Impact factor: 6.244

4.  Prognosis Value of microRNA-3677-3p in Lung Adenocarcinoma and Its Regulatory Effect on Tumor Progression.

Authors:  Jian Zhao; Hanbing Yu; Tianci Han; Xiangyu Zhu
Journal:  Cancer Manag Res       Date:  2021-12-18       Impact factor: 3.989

5.  Nutritional features-based clustering analysis as a feasible approach for early identification of malnutrition in patients with cancer.

Authors:  Liangyu Yin; Jie Liu; Xin Lin; Na Li; Jing Guo; Yang Fan; Ling Zhang; Muli Shi; Hongmei Zhang; Xiao Chen; Chang Wang; Li Deng; Wei Li; Zhenming Fu; Chunhua Song; Zengqing Guo; Jiuwei Cui; Hanping Shi; Hongxia Xu
Journal:  Eur J Clin Nutr       Date:  2021-01-18       Impact factor: 4.884

6.  AMPK α1 Downregulates ROS Levels Through Regulating Trx Leading to Dysfunction of Apoptosis in Non-Small Cell Lung Cancer.

Authors:  Daohui Gong; Ying Li; Yuxiu Wang; Beiyuan Chi; Jun Zhang; Jianjun Gu; JunJun Yang; Xingxiang Xu; Suwei Hu; Lingfeng Min
Journal:  Onco Targets Ther       Date:  2020-06-23       Impact factor: 4.147

Review 7.  Role of HSP60/HSP10 in Lung Cancer: Simple Biomarkers or Leading Actors?

Authors:  Alberto Fucarino; Alessandro Pitruzzella
Journal:  J Oncol       Date:  2020-03-30       Impact factor: 4.375

8.  Exosome-Reversed Chemoresistance to Cisplatin in Non-Small Lung Cancer Through Transferring miR-613.

Authors:  Delong Li; Debin Meng; Rungui Niu
Journal:  Cancer Manag Res       Date:  2020-09-03       Impact factor: 3.989

9.  The surgical perspective in neoadjuvant immunotherapy for resectable non-small cell lung cancer.

Authors:  Long Jiang; Jia Huang; Shanshan Jiang; Wenwen Rong; Yaofeng Shen; Chongwu Li; Yu Tian; Junwei Ning; Xiaoke Chen; Yunhai Yang; Zhengping Ding; Ziming Li; Qingquan Luo
Journal:  Cancer Immunol Immunother       Date:  2021-01-29       Impact factor: 6.968

10.  miR-16 regulates proliferation and invasion of lung cancer cells via the ERK/MAPK signaling pathway by targeted inhibition of MAPK kinase 1 (MEK1).

Authors:  TianMing Chen; Qi Xiao; XiaoJun Wang; ZhongQiu Wang; JingWen Hu; Zhi Zhang; ZhuNan Gong; ShiLin Chen
Journal:  J Int Med Res       Date:  2019-08-04       Impact factor: 1.671
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.